Non-aqueous polar aprotic peptide formulations
DC CAFCFirst Claim
Patent Images
1. A stable non-aqueous formulation of a peptide compound comprising:
- a) at least one peptide compound; and
b) at least one polar aprotic solvent,wherein said peptide compound is an LHRH-related compound.
3 Assignments
Litigations
0 Petitions
Accused Products
Abstract
This invention relates to stable non-aqueous polar aprotic formulations of peptide compounds. These stable formulations comprise peptide in non- aqueous polar aprotic solvent. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug.
-
Citations
34 Claims
-
1. A stable non-aqueous formulation of a peptide compound comprising:
-
a) at least one peptide compound; and b) at least one polar aprotic solvent, wherein said peptide compound is an LHRH-related compound. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13, 14)
-
-
9. A stable non-aqueous formulation of a peptide compound comprising:
-
a) at least one peptide compound; b) at least one polar aprotic solvent; and c) a non-aqueous protic solvent. - View Dependent Claims (16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
-
15. A stable non-aqueous formulation of a peptide compound comprising:
-
(a) at least one peptide compound; and (b) at least one polar aprotic solvent, wherein said peptide compound is selected from the group consisting of glucagon, glucagon like peptide-1 and glucagon like peptide-2. - View Dependent Claims (26, 27, 28, 29, 30, 31, 32, 33, 34)
-
Specification